Sahasrabuddhe V V, Mwanahamuntu M H, Vermund S H, Huh W K, Lyon M D, Stringer J S A, Parham G P
Vanderbilt University, 2215 Garland Avenue, 319 Light Hall, Nashville, TN 37232, USA.
Br J Cancer. 2007 May 7;96(9):1480-3. doi: 10.1038/sj.bjc.6603737. Epub 2007 Apr 17.
We screened 145 HIV-infected non-pregnant women at a tertiary care centre in Lusaka, Zambia. Liquid-based cytology and human papillomavirus (HPV) genotyping with PGMY09/11 biotinylated primers (Roche Linear Array HPV genotyping test) maximised sensitivity of cytology and HPV assessments. Among high-risk (HR) types, HPV 52 (37.2%), 58 (24.1%) and 53 (20.7%) were more common overall than HPV 16 (17.2%) and 18 (13.1%) in women with high-grade squamous intraepithelial lesions or squamous cell carcinoma (SCC) on cytology. High-risk HPV types were more likely to be present in women with CD4+ cell counts <200 microl(-1) (odds ratios (OR): 4.9, 95% confidence intervals (CI): 1.4-16.7, P=0.01) and in women with high-grade or severe cervical cytological abnormalities (OR: 8.0, 95% CI: 1.7-37.4, P=0.008). Human papillomavirus diversity in high-grade lesions and SCC on cytology suggests that HPV 16- and 18-based vaccines may not be adequately polyvalent to induce protective immunity in this population.
我们在赞比亚卢萨卡的一家三级医疗中心对145名未怀孕的HIV感染女性进行了筛查。采用基于液基的细胞学检查以及使用PGMY09/11生物素化引物的人乳头瘤病毒(HPV)基因分型(罗氏线性阵列HPV基因分型检测),可最大程度提高细胞学和HPV评估的敏感性。在高危(HR)型别中,总体而言,细胞学检查显示为高级别鳞状上皮内病变或鳞状细胞癌(SCC)的女性中,HPV 52型(37.2%)、58型(24.1%)和53型(20.7%)比HPV 16型(17.2%)和18型(13.1%)更为常见。高危HPV型别更有可能出现在CD4 +细胞计数<200微升⁻¹的女性中(比值比(OR):4.9,95%置信区间(CI):1.4 - 16.7,P = 0.01)以及高级别或严重宫颈细胞学异常的女性中(OR:8.0,9 <5% CI:1.7 - 37.4,P = 0.008)。细胞学检查显示高级别病变和SCC中的人乳头瘤病毒多样性表明,基于HPV 16型和18型的疫苗可能在该人群中诱导保护性免疫的多价性不足。